All News

Three phase 3 trials will assess datopotamab deruxtecan-based treatments in patients with nonsquamous non-small cell lung cancer.

Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.

Preoccupied with other worries during October, a month full of cancer anniversaries, I reflect on how Pinktober caught up with me.

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to learn more about how patients with breast cancer can connect with each other.

CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center for a webinar to discuss the importance of self-advocacy.

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to discuss supporting others with breast cancer.

Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.

Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.

An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.

A phase 2 clinical trial of a new brain cancer treatment is underway.

Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.

An expert answers prostate cancer questions from a recent CURE Educated Patient Summit.

Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases.

An expert told CURE that patients with cancer should discuss palliative care options with their team “as early as possible.”

This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.

Stivarga improved survival and delayed disease progression in patients with refractory advanced gastric and esophagogastric junction cancer.

Carla Deschamps shares her experience with colon cancer and how her brother, sisters and parents helped her through the journey.

Receiving radiation therapy for breast cancers harboring TP53 germline variants may cause secondary cancers, but risk estimates are unconfirmed.

An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.

Two colleagues of an oncology nurse highlight her utmost respect for patients and as a liaison to the greater team.

When I was diagnosed with a rare and aggressive kidney cancer, I turned to God and He has helped me through my journey, each step of the way.

Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.

The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.

Researchers have found that engaging in aerobic physical activity results in modest depression reduction among some patients with cancer.

During my lung cancer journey, I learned a few important ways to help me lessen the apprehension I felt, including meditation.

From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.